ZRG Partners Acquires HM Long Global Partners, Bolstering Growing Global Life Sciences Executive Search Practice
ZRG Partners, recognized as the fastest growing search firm in the Americas, has announced the acquisition of certain assets of HM Long Global Partners and the hiring of key leaders, expanding one of the most dynamic global Life Sciences recruiting teams in the world.
As part of the asset acquisition agreement, Helga Long, formerly the Chair and CEO of HM Long/RSVP Group, is joining ZRG Partners with a prestigious career. Helga is considered one of the world’s top executive search professionals in the Life Sciences sector, as measured by her body of work in this niche. She has helped companies globally for over 30 years with senior level talent acquisition. Prior to her merger of HM Long Global Partners and RSVP, Helga spent 10 years with another leading global search firm as a Vice Chairman of the firm’s Life Sciences Practice. Helga will remain as the CEO of HM Long Global, a division of ZRG Partners, and after the integration of the assets, will assume the role of Chief Client Officer in ZRG’s global Life Sciences practice working with the ZRG team in supporting clients around the world.
Joining Helga will be several key leaders and support team members who have been working together for over a decade including Charles Rohaut, Managing Director in France. Derick Haire will join as Senior Client Partner in Texas, as well as Lydia Coleman in Virginia.
Commenting on the acquisition, Larry Hartmann, CEO of ZRG Partners related, “Our current Life Sciences team, led by Adam El Din, as Global Practice Head and David Fortier, North American Leader, have delivered amazing results the past few years. The addition of Helga Long and the team creates the most powerful super-boutique solution for Life Sciences clients globally. We could not be more excited about the addition of the entire team that has worked together in the market for years.”
Helga Long stated, “I am thrilled to join a platform where the focus is on the client and how we can serve them best. ZRG’s sophisticated, client centric data and analytics approach in the search process will only enhance the level of work our team has already been doing in the market and create even stronger client partnerships. The alliance with ZRG creates a true 1+1 = 3 combination. I look forward to continuing to serve my clients in delivering top life science talent globally as part of this dynamic organization.”
Adam El Din commented, “I am delighted that Helga, Charles and their team are joining ZRG partners. Our team will capitalize on our expertise and network to offer our clients a partnership second to none.”
About ZRG Partners
ZRG Partners is a progressive mid-sized global executive search firm that uses a proven, data-driven approach. For over 17 years, clients have trusted ZRG Partners to recruit top talent around the world. ZRG Partners is recognized as one of the fastest growing executive search firms in the industry driven by the firm’s client focused, results driven approach grounded in integrity.
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Madison Realty Capital Provides $64.0 Million Construction Financing for 200 Kent Avenue Development in Williamsburg, Brooklyn17.11.2017 16:20 | Pressemelding
Madison Realty Capital (MRC) announced the closing of a $64.0 million construction loan for 200 Kent Avenue, a 117,326 square foot mixed-use development located in Williamsburg, Brooklyn. The retail portion of the property, which will include over 600 feet of frontage, will be anchored by a popular national grocery chain. Overall, the project will offer 50,101 square feet of retail space, 22,055 square feet of office and restaurant space, and 45,170 square feet of parking. “We continue to establish MRC as the one-stop shop for financing transitional real estate, including ground-up development deals like 200 Kent Avenue,” said Josh Zegen, Co-Founder and Managing Principal of MRC. “In this case, we’re working with a repeat MRC borrower who understands our ability to execute efficiently, given our firm’s up-to-the minute knowledge of local market conditions and non-bureaucratic approach to
Ncardia Announces Completion of €10.5M Investment Round17.11.2017 12:31 | Pressemelding
Ncardia, an emerging drug discovery and development stem cell technology company whose mission is to deliver cardiac and neural solutions based on its best-in-class human induced pluripotent stem cell (iPSC)-derived technology, today announced the completion of a €10.5 million series B financing round. The round was led by Épimède, a Belgium venture capital firm. Ncardia is a privately-held company with operations in Europe and the US, that produces and commercializes high-quality, fully-functional human iPSC-derived cardiovascular and neuronal cell types. Using its cell products, Ncardia develops and commercializes assay services for drug safety and efficacy testing. Additionally the company has built up a strong portfolio of patents covering the use of stem cell models for these applications. Stefan Braam, CEO of Ncardia, commented: “At Ncardia, important progress h
Double Win for Vocalink at the 2017 Payments Awards17.11.2017 09:35 | Pressemelding
Vocalink, a Mastercard company, was last night awarded with two prestigious awards - The Overall Winner and the Payments Infrastructure of the Year Award, for its leading technology and expertise, and in recognition for a milestone year that saw Vocalink’s solutions transform the way people and businesses move money across the globe. 2017 saw Vocalink deliver ground-breaking immediate payments solutions both in the US and Thailand as well as enabling access to the UK payments industry through their payments gateway solution PayPort. The business also saw the launch of the new image based cheque clearing system, creating a robust and more efficient system in the UK. RTP ® in the US: This week, Vocalink announced the launch of RTP® (Real-Time Payments) in the US on behalf of The Clearing House; one of the most comprehensive real-tim
Envion AG: Start-up from the Heart of Berlin Has Pioneered Decentralized Mobile Mining by Combining Blockchain with Regenerative Energy17.11.2017 09:00 | Pressemelding
Envion AG has created a technology for the first truly mobile data-center that uses low-priced local energy to mine a broad spectrum of cryptocurrencies (Bitcoin, Ethereum, etc.). By harvesting locally available clean energy right at the source, envion can operate at lower costs than competitors and at the same time reduces the CO2 footprint of the blockchain industry. Envion aims at decentralizing the highly-concentrated mining market (China holds 80% in Bitcoin mining) and at bringing control of the market back to the users. That’s why envion gives 100% of its mining profits back to its community. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171117005011/en/ Envion - World's Most Profitable Standard of Self-Expanding Crypto Infrastructure (Photo: Business Wire) Current challenges in the energy
Chugai's HEMLIBRA® Receives the World's First Regulatory Approval from FDA for Hemophilia A with Inhibitors16.11.2017 23:30 | Pressemelding
Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced today that the U.S. Food and Drug Administration (FDA) has approved the bispecific antibody emicizumab (US product name: HEMLIBRA®) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A (congenital factor VIII deficiency) with factor VIII inhibitors. This represents the first regulatory approval for HEMLIBRA® around the world. The US Biologics License Application (BLA) was submitted by Genentech, a member of Roche Group. “We are pleased that HEMLIBRA, a biopharmaceutical created by Chugai scientists based on their exceptional idea, has received its first regulatory approval,” said Chugai’s President & COO, Tatsuro Kosaka. “HEMLIBRA is a first in class biopharmaceutical which is an advancement on the current limited treatment options available for pat
Pacific Drilling Receives Approval of First Day Motions16.11.2017 22:08 | Pressemelding
Pacific Drilling S.A. (OTCPink: PACDQ) (“Pacific Drilling” or the “Company”) today announced that the United States Bankruptcy Court for the Southern District of New York has granted the relief requested by the Company in certain first day motions related to ordinary course business activities, subject to certain modifications at the request of the Court, the United States Trustee and stakeholders. The approved motions give us the authority to, among other things, continue to pay employee wages and benefits without interruption, to utilize our current cash management system, and to pay certain foreign and critical vendors for goods and services provided prior to the petition date. All vendors will be paid in full and in cash on normal payment terms for all goods and services provided on or after the petition date. Paul Reese, Chief Executive Officer of Pacific Drilling, said, “With the
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom